Otros idiomas TrivarX Limited

Acciones

TRI

AU0000300196

Precio de cierre Australian S.E. Otros sitios de cotización 00:00:00 21/05/2024			Varia. Cinco días.	Varia. 1 de enero.
0,027 ^AUD	-10,00 %		-6,90 %	-10,00 %

02/05	TrivarX recibe compromisos firmes para una emisión de acciones de 2,5 millones de dólares australianos; las acciones suben un 27	MT
28/02	TrivarX Limited informa de los resultados de ganancias para el semestre finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

TrivarX Receives Firm Commitments for AU$2.5 Million Share Issuance; Shares Jump 27%	02/05
TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2023	28/02
TrivarX Signs Collaboration with Northern Michigan University on Sleep Research	09/02
TrivarX Secures R&D Tax Rebate for Fiscal Year 2023; Shares Fall 4%	08/02
Over Half of Patients On Track for Completion in TrivarX's SAMDE Study	07/02
TrivarX Undertaking 1-for-20 Securities Consolidation	18/10/23
Medibio Limited has Changed its Name to TrivarX Limited	06/10/23
Medibio Limited Announces Dr. Thomas Young Will Transition from His Role as Part-Time Chief Executive Officer to Non-Executive Director	06/10/23
Medibio Limited Announces Dr. Thomas Young Will Transition from His Role as Part-Time Chief Executive Officer to Non-Executive Director	06/10/23
Medibio Begins Phase Two Trial for Sleep Algorithm	04/09/23
TrivarX Limited Reports Earnings Results for the Full Year Ended June 30, 2023	31/08/23
Medibio Completes Phase One Depressive Episode Sleep Trial	24/07/23
US FDA Denies Breakthrough Device Designation for Medibio’s Depression Diagnostic Device	21/07/23
Medibio Completes Shares Purchase Plan	29/05/23
Medibio Adds Executive Director Role to CEO, Changes Principal Pace of Business	12/04/23
Medibio Limited Announces Board & Management Changes	12/04/23
Medibio Limited Announces Change of Registered Office and Principal Place of Business	12/04/23
Medibio Limited Announces Resignation of Matt Mesnik as Non-Executive Director	16/03/23
Medibio Limited Lodges Breakthrough Device Designation with FDA	26/02/23
TrivarX Limited Reports Earnings Results for the Half Year Ended December 31, 2022	24/02/23

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas TrivarX Limited

Acciones

TRI

AU0000300196

Otros idiomas

Filtros